CD274 and breast carcinoma: To further explore the roles of PD-L1 N-linked glycosylation in regulating its functional effects in breast cancer cells, each of its four N-linked glycosylation sites (N35, N192, N200 and N219; [25,26,27]) was separately mutated, and a mutant of all four sites combined was also generated.